More than ever, clinicians need regularly updated reviews given the continuously increasing
amount of new information regarding innovative cervical cancer prevention methods. A …

Strong evidence now supports the adoption of cervical cancer prevention strategies that
explicitly focus on persistent infection with the causal agent, human papillomavirus (HPV) …

Every year cervical cancer affects more than 300,000 people, and on average one woman is
diagnosed with cervical cancer every minute. Early diagnosis and classification of cervical …

Background Cervical cancer screening has traditionally been based on cervical cytology.
Given the aetiological relationship between human papillomavirus (HPV) infection and …

Cervical cancer is the second most common cancer in women worldwide, and knowledge
regarding its cause and pathogenesis is expanding rapidly. Persistent infection with one of …

Abstract European Guidelines for Quality Assurance in Cervical Cancer Screening have
been initiated in the Europe Against Cancer Programme. The first edition established the …

Objective To assess the relative risk of perinatal mortality, severe preterm delivery, and low
birth weight associated with previous treatment for precursors of cervical cancer. Data …

Screening for cervical cancer precursors by cytology has been very successful in countries
where adequate resources exist to ensure high quality and good coverage of the population …

OBJECTIVE: To compare test performance characteristics of conventional Pap tests and
liquid-based cervical cytology samples. DATA SOURCES: Eligible studies, published …

Background Testing for human papillomavirus (HPV) DNA is reportedly more sensitive than
cytology for the detection of high-grade cervical intraepithelial neoplasia (CIN). The …